Embryo freezing for preventing ovarian hyperstimulation syndrome: A Cochrane Review

Human Reproduction

Volumn 17, Issue 11, 2002, Pages 2787-2794

  D'Angelo, A ^a   Amso, N N ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Elective cryopreservation; I.v. albumin; Ovarian hyperstimulation syndrome; Randomized controlled trials; Systematic review

Indexed keywords

ALBUMIN; CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN AGONIST; SERUM ALBUMIN;

CLINICAL TRIAL; COCHRANE LIBRARY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOPRESERVATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOWN REGULATION; EMBRYO; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; IATROGENIC DISEASE; INCIDENCE; INTRACYTOPLASMIC SPERM INJECTION; META ANALYSIS; OUTCOMES RESEARCH; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PRACTICE GUIDELINE; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; REVIEW; STATISTICAL ANALYSIS; SUPEROVULATION; FEMALE; INTRAVENOUS DRUG ADMINISTRATION;

FALLOPIA;

CRYOPRESERVATION; EMBRYO; EMBRYO TRANSFER; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; OVARIAN HYPERSTIMULATION SYNDROME; RANDOMIZED CONTROLLED TRIALS; SERUM ALBUMIN;

EID: 0036852085     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/17.11.2787     Document Type: Review

References (41)

1. Aboulghar, M., Evers, J.H. and Al-Inany, H. (1999) Intra-venous albumin for preventing severe ovarian hyperstimulation syndrome (Cochrane Review). In The Cochrane library, Issue 4. Update Software, Oxford, UK.
2. Agrawal, R, Conway, G., Sladkevicius, P. et al. (1998) Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and policystic ovaries. Fertil. Steril., 70, 651-658.
3. Allegra, A., Termine, N., Raineri, L. et al. (1991) Iperstimolazione ovarica e gravidanza gemellare in una paziente in trattamento con analogo del GnRH e gonadotropine senza somministrazione di midcycle hCG. Riv. Ostet. Ginecol. Perinat., 2, 209-211.
4. Al-Shawaf, T., Zosmer, A., Hussain, S. et al. (2001) Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified 'coasting' strategy based on ultrasound identification of high-risk patients. Hum. Reprod., 1, 24-30.
5. Amso, N.N., Ahuja, K.K., Morris, N. et al. (1990) The management of predicted ovarian hyperstimulation involving gonadotropin-releasing hormone analog with elective cryopreservation of all pre-embryos. Fertil. Steril., 53, 1087-1090.
6. Araujo, E., Bernardini, L., Frederick, J.L. et al. (1994) Prospective randomized human chorionic gonadotropin versus intramuscular progesterone for luteal-phase support in assisted reproduction. J. Assist. Reprod. Genet., 11, 74-78.
7. Asch, R.H., Ivery, G., Goldsman, M. et al. (1993) The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome. Hum. Reprod., 8, 1015-1020.
8. Awonuga, A.D., Pittrof, R.J., Zaidi, J. et al. (1996) Elective cryopreservation of all embryos in women at risk of developing ovarian hyperstimulation syndrome may not prevent the condition but reduces the live birth rate. J. Assist. Reprod. Genet., 13, 401-406.
9. Brinsden, P.R., Wada, I., Tan S.L. et al. (1995) Diagnosis, prevention and management of OHSS: review. Br. J. Obstet. Gynaecol., 102, 767-772.
10. Chen, C., Wu, M., Yang, J. et al. (1997) Intravenous albumin does not prevent the development of severe ovarian hyperstimulation syndrome. Fertil. Steril., 68, 287-291.
11. Dahl Lyons, C.A., Wheeler, C.A., Frishman, G.N. et al. (1994) Early and late presentation of ovarian hyperstimulation syndrome: two distinct entities with different risk factors. Hum. Reprod., 9, 792-799.
12. Doldi, N., Destefani, A., Gessi, A. et al. (1999) Human albumin enhances expression of vascular endothelial growth factor in cultured human luteinizing granulosa cells: importance in ovarian hyperstimulation syndrome. Hum. Reprod., 14, 1157-1159.
13. Egbase, P.E., Al Sharhan, M. and Grudzinskas, J.G. (1999) Early unilateral follicular aspiration compared with coasting for the prevention of severe ovarian hyperstimulation syndrome: a prospective randomized study. Hum. Reprod., 14, 1421-1425.
14. Ferraretti, A.P., Gianaroli, L., Magli, C. et al. (1999) Elective cryopreservation of all pronucleate embryos in women at risk of ovarian hyperstimulation syndrome: efficiency and safety. Hum. Reprod., 14, 1457-1460.
15. Forman, R.G., Frydman, R., Egan, D. et al. (1990) Severe ovarian hyperstimulation syndrome using agonists of gonadotrophin releasing hormone for in vitro fertilization: a European series and a proposal for prevention. Fertil. Steril., 53, 502-509.
16. Golan, A., Ron-El, R., Herman, A. et al. (1989) Ovarian hyperstimulation syndrome: an update review. Obstet. Gynaecol. Surv., 44, 430-440.
17. Goldsman, M.P., Pedram, A., Dominiguez, C.E., et al. (1995) Increased capillary permeability induced by human follicular fluid: a hypothesis for an ovarian origin of the hyperstimulation syndrome. Fertil. Steril., 63, 268-272.
18. Gonen, Y., Balakier, H., Powell, W. et al. (1990) Use of GnRH agonist to trigger follicular maturation for in vitro fertilization. J. Clinical Endocrinol. Metab., 71, 918-923.
19. Isik, A.Z., Gokmen, O., Zeyneloglu, H.B. et al. (1996) Intravenous albumin prevents moderate-severe ovarian hyperstimulation in in-vitro fertilization patients: a prospective, randomized and controlled study. Eur. J. Obstet. Gynecol. Reprod. Biol., 70, 179-183.
20. Lipitz, S., Zion, B.R., Bider, D. et al. (1991) Quintuplet pregnancy and third degree ovarian hyperstimulation despite witholding humam chorionic gonadotropin. Hum. Reprod., 6, 1478-1479.
21. MacDougall, M.J., Tan, S.L. and Jacobs, H.S. (1992) In vitro fertilization and the ovarian hyperstimulation syndrome. Hum. Reprod., 7, 579-600.
22. Munoz, E., Cuneo, S., Ferro, J. et al. (2000) Intravenous albumin in the prevention of ovarian hyperstimulation syndrome. Hum. Reprod., 15 (Abst. Book), P-102 p. 139.
23. Navot, D., Bergh, P.A. and Laufer, N. (1992) Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil. Steril., 58, 249-261.
24. Ndukwe, G., Thornton, S., Fishel, S. et al. (1997) Severe ovarian hyperstimulation syndrome: is it really preventable by prophylactic intravenous albumin? Fertil. Steril., 68, 851-854.
25. Ng, E., Leader, A., Claman, P. et al. (199) Intravenous albumin does not prevent the development of severe ovarian hyperstimulation syndrome in an in-vitro fertilization programme. Hum. Reprod., 10, 807-810.
26. Panay, N., Iammarrone, E., Zosmer, A. et al. (1999) Does the prophylactic use of intravenous albumin prevent ovarian hyperstimulation syndrome? A randomized prospective study. Hum. Reprod., 14, 105.
27. Pattinson, H.A., Hignett, M., Dunphy, B.C. et al. (1994) Outcome of thaw embryo transfer after cryopreservation of all embryos in patients at risk of ovarian hyperstimulation syndrome. Fertil. Steril., 62, 1192-1196.
28. Queenam, J.T. Jr, Veeck, L.L., Toner, J.P. et al. (1997) Cryopreservation of all prezygotes in patients at risk of severe hyperstimulation does not eliminate the syndrome, but the chances of pregnancy are excellent with subsequent frozen-thaw transfers. Hum. Reprod., 12, 1573-1576.
29. Rabau, E., Serr, D.M., David, A. et al. (1967) Human menopausal gonadotropins for anovulation and sterility. Am. J. Obstet. Gynaecol., 98, 92-98.
30. Schenker, J.G. and Weinstein, D. (1978) Ovarian hyperstimulatin syndrome: a current survey. Fertil. Steril., 30, 255-268.
31. Segal, S. and Casper, R.F. (1992) Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin for triggering follicular maturation in in vitro fertilization. Fertil. Steril., 57, 1254-1258.
32. Shaker, A.G., Zosmer, A., Dean, N. et al. (1996) Comparison of intravenous albumin and transfer of fresh embryos with cryopreservation of all embryos for subsequent transfer in prevention of ovarian hyperstimulation syndrome. Fertil. Steril., 65, 992-996.
33. Shalev, E., Giladi, Y., Matilsky, M. et al. (1995). Decreased incidence of severe ovarian hyperstimulation syndrome in high-risk in-vitro fertilization patients receiving intravenous albumin: a prospective study. Hum. Reprod., 10, 1373-1376.
34. Sher, G., Zouves, C., Feinman, M. et al. (1993) Eliminating the risk of life-endangering complications following overstimulation with menotropin fertility agents: a report on women undergoing in vitro fertilization and embryo transfer. Obstet. Gynaecol., 81, 1009-1011.
35. Shoham, Z., Weissman, A., Barash, A. et al. (1994) Intravenous albumin for the prevention of severe ovarian hyperstimulation syndrome in an in vitro fertilization program: a prospective, randomized, placebo-controlled study. Fertil. Steril., 62, 137-142.
36. Society for Assisted Reproductive Technology, the American Fertility Society (1992) In vitro fertilization-embryo transfer (IVF-ET) in the United States: 1990 results from the IVF-ET registry. Fertil. Steril., 57, 15-24.
37. Titinem, A., Husa, L., Tulppala, M. et al. (1995) The effect of cryopreservation in prevention of ovarian hyperstimulation syndrome. Br. J. Obstet. Gynaecol., 10, 326-329.
38. Tsirigotis, M. and Craft, I. (1994) Ovarian Hyperstimulation Syndrome (OHSS): how much do we really know about it? Eur. J. Obstet. Gynaecol., 55, 151-155.
39. Wada, I., Matson, P.L., Troup, S.A. et al. (1990) Ovarian hyperstimulation syndrome in GnRH-a/hMG cycles for IVF and GIFT. J. Obstet. Gynaecol., 11, 88-89.
40. Wada, I., Matson, P.L., Troup, S.A. et al. (1992) Outcome of treatment subsequent to the elective preservation of all embryos from women at risk of ovarian hyperstimulation syndrome. Hum. Reprod., 7, 962-966.
41. Wada, I., Matson, P.L., Troup, S.A. et al. (1993) Does elective cryopreservation of all embryos from women at risk of ovarian hyperstimulation syndrome reduce the incidence of the condition? Br. J. Obstet. Gynaecol., 100, 265-269.